Antiretroviral Regime for Viral Eradication in Newborns

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
HIV/AIDS and Infections
Interventions
DRUG

Zidovudine

Dose will be adjusted according to the child's weight.

DRUG

Nevirapine

Dose will be adjusted according to the child's weight.

DRUG

Lamivudine

Dose will be adjusted according to the child's weight.

DRUG

Lopinavir/ritonavir

Dose will be adjusted according to the child's weight.

Trial Locations (5)

Unknown

Maternal and Child Health Hospital of Guangdong Province, Guangzhou

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning

Maternal and Child Health Hospital of Sichuan Province, Chengdu

Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

Maternal and Child Health Hospital of Yunan Province, Kunming

All Listed Sponsors
collaborator

National Center for AIDS/STD Control and Prevention, China CDC

OTHER_GOV

collaborator

Maternal and Child Health Hospital of Yunan Province

UNKNOWN

collaborator

Maternal and Child Health Hospital of Sichuan Province

UNKNOWN

collaborator

Maternal and Child Health Hospital of Guangxi Province

UNKNOWN

collaborator

Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region

UNKNOWN

collaborator

Guangdong Provincial Maternal and Child Health Hospital

OTHER

lead

National Center for Women and Children's Health, China CDC

OTHER_GOV

NCT02712801 - Antiretroviral Regime for Viral Eradication in Newborns | Biotech Hunter | Biotech Hunter